|
Press Release: Second Annual Summit on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies Features What's Next for the States
- A Hybrid Conference, Internet Event and Training Tool
- March 3 - 5, 2010
- Onsite at the Renaissance Washington DC Hotel, Washington, DC
- Online In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
- www.DisclosureSummit.com
PRESS RELEASE
Phone: 800-503-0112
Email: registration@hcconferences.com
Website: www.DisclosureSummit.com
|
|
FEATURING WHAT'S NEXT WITH THE STATES
|
On Thursday, March 4, 2010 the Summit will offer a session What's Next for the States: Pushing the Envelope on Disclosure and Gift Bans featuring:
Julie Brill, Esq.
Senior Deputy Attorney General, Chief, Consumer Protection Division, North Carolina Department of Justice, Raleigh, NC |
Allan Coukell
Director of Policy, Prescription Project, Winner, 2007 Edward R. Murrow Award, Boston, MA |
Melissa J. Lopes, Esq.
Deputy General Counsel, Massachusetts Department of Public Health, Boston, MA |
George Till, MD
State Legislator, Vermont, Jericho, VT |
Jack T. Tanselle
Director, Navigant Consulting, Inc., Chicago, IL (Moderator) |
|
|
|
EARLY REGISTRATION DISCOUNT EXTENDED
- SAVE $200 -
|
Register by Friday, January 29, 2010 for Early Bird discount and save $200.
Click here to register.
|
|
|
WASHINGTON DC USA -- CME UPDATE NEWS SERVICE™ -- JANUARY 20, 2010: The National Disclosure Summit, www.DisclosureSummit.com, to be held on March 3 - 5, 2010 at the Renaissance Washington DC Hotel in Washington, DC today announced that it will offer a session on What's Next for the States: Pushing the Envelope on Disclosure and Gift Bans.
|
SECOND ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
March 3 - 5, 2010
Onsite:
Renaissance Washington DC Hotel
Online:
Live and Archived for 6 Months
|
SUMMIT GRANTORS
|
SILVER GRANTOR
|
|
|
BRONZE GRANTORS
|
|
|
|
|
|
|
NEWLY CONFIRMED KEYNOTE SPEAKER
|
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General,US Department of Health and Human Services, Washington, DC
|
BROCHURE NOW AVAILABLE
|
|
Click here to download brochure.
|
|
| TOPICS COVERED |
PRECONFERENCE: DISCLOSURE BOOT CAMP
Understanding the Forces Driving Disclosure: State Legislators, MedPAC, US Congress: The Sunshine Act, State Enforcers, OIG, Settlements and CIAs
Introduction to Existing State Disclosure Laws and Regulations: Massachusetts, Minnesota, Nevada, Vermont, Washington, DC and West Virginia
Aggregate Spend 101: The Nuts and Bolts of an Aggregate Spend Program
THE SUMMIT
How Disclosure and Transparency are Reshaping Pharmaceutical and Device Marketing and Compliance
Update on the Physician Payments Sunshine Act
Pushing the Envelope: What's Next for the States?
The Evolving Role of the OIG
How Disclosure Will Reshape State and Federal Enforcement Initiatives
Early Lessons from Lilly and Merck's Initial Public Disclosures
The Physician-Industry Relationship: Flaws and Solutions
How to Manage New Clinical Trial Disclosure Requirements
Capturing the Right Information and Ensuring Its Integrity
Benchmarking Data: Comparing Your Practices to Those of Your Peers
Industry Disclosure Best Practice Roundtable
|
DISCLOSURE TRAINING PROGRAM
|
|
THE DISCLOSURE SUMMIT IS DEDICATED TO THE MEMORY OF MIKE BIGELOW (1967 - 2009)
Former Assistant General Counsel at Eli Lilly
|
|
|
|
SECOND ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Pharma Congress Conference
March 3 - 5, 2010
|
ONSITE
Renaissance Washington DC Hotel
Washington, DC
|
OR |
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
 |
|
|
|
CO CHAIRS
|
Eve Costopoulos
Vice President, Corporate Compliance, Schering-Plough Corporation, Kenilworth, NJ |
Jonathon L. Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ |
Daniel A. Kracov, Esq.
Partner, Arnold & Porter, Washington, DC |
Paul J. Silver
Managing Director, Huron Consulting Group, LLC, Atlanta, GA |
Jack T. Tanselle
Director, Navigant Consulting, Inc., Chicago, IL |
Michael Varlotta
Senior Director, Department of Medical Education, Medical Affairs, Centocor, a wholly owned subsidiary of Johnson & Johnson, Horsham, PA
|
|
|
|
|
FEDERAL AND STATE POLICY MAKERS
|
Christopher J. Armstrong, Esq.
Investigative Counsel, Committee on Finance, US Senate, Staff, Senator Charles Grassley, Ranking Member, Washington, DC |
Jack Mitchell
Chief of Oversight and Investigations, Special Committee on Aging, US Senate, Staff, Senator Herb Kohl (D/WI), Washington, DC |
George Till, MD
State Legislator, Vermont, Underhill, VT
|
|
|
|
|
FEDERAL AND STATE PROSECUTORS AND REGULATORS
|
Julie Brill, Esq.
Senior Deputy Attorney General, Chief, Consumer Protection Division, North Carolina Department of Justice, Raleigh, NC |
Melissa J. Lopes, Esq.
Deputy General Counsel, Massachusetts Department of Public Health, Boston, MA |
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
|
James G. Sheehan, Esq.
New York State Medicaid, Inspector General, Former Associate United States Attorney, US Attorney's Office, Eastern District of Pennsylvania, Albany, NY |
Gerald Sullivan, Esq.
Assistant United States Attorney, US Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA
|
|
|
|
|
POLICY EXPERTS
|
Guy M. Chisolm, III, PhD
Director, Innovation Management and Conflict of Interest Program, Vice Chairman, Lerner Research Institute, Cleveland Clinic, Cleveland, OH |
Allan Coukell
Director of Policy, Prescription Project, Winner, 2007 Edward R. Murrow Award, Boston, MA |
Bernard Lo, MD
Professor of Medicine and Director Program in Medical Ethics, Department of Medicine, University of California, San Francisco, Chair, Committee on Conflict of Interest in Medical Research, Education, and Practice; Institute of Medicine, San Francisco, CA
|
Frank W. LoGerfo, MD
William V. McDermott Distinguished Professor of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA |
James Roosevelt, Jr., Esq.
President and Chief Executive Officer, Tufts Health Plan, Former Associate Commissioner for Retirement Policy, US Social Security Administration, Boston, MA |
Thomas P. Stossel, MD
Director, Translational Medicine Division, Senior Physician, Hematology Division, American Cancer Society, Professor of Medicine, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA
|
|
|
|
|
|
COMPLIANCE PROFESSIONALS AND INHOUSE COUNSEL
|
Diane Cruz-Burke, Esq.
Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN |
Kevin T. Gordon
Associate Director, Application and Data Services, Cephalon, Frazer, PA |
Jacqueline K. Huber
Corporate Vice President and Chief Compliance Officer, Biomet, Inc., Warsaw, IN
|
Beth Margerison
Associate Director, Ethics and Compliance, Novartis Pharmaceuticals Corporation, East Hanover, NJ |
Brian S. McGowan, PhD, CCMEP
Senior Director, Independent Medical Education, Pfizer, Collegeville, PA
|
Jeffrey S. Paden
Compliance Officer, GlaxoSmithKline North America, Durhan, NC
|
Heather Reilly Powell, Esq.
Director, Compliance Training and Reporting, Daiichi Sankyo, Inc., Former Associate Director, Global Compliance, Cephalon, Inc., Parsippany, NJ |
Geralyn Ritter
Vice President, Global Public Policy and Corporate Responsibility, Merck & Co., Inc., Former Senior VP, International Affairs, PhRMA, White Plains, NY
|
Trudy J. Seeley, Esq.
Compliance Manager, State Law Compliance, and US Corporate Compliance, sanofi-aventis, Bridgewater, NJ |
Betsy Van Hecke
Vice President Ethics and Compliance, MedTronic Spinal and Biologics, Minneapolis, MN
|
|
|
|
|
A PANEL OF COMPLIANCE TECHNOLOGY EXPERTS
|
Michael Bell, Esq.
President, R-Squared, Princeton Junction, NJ |
Mitch Chi
Senior Vice President Sales, Health Market Science, King of Prussia, PA |
Kim Life, Esq.
Principal, Life Compliance Solutions, Former Associate Director, Business Conduct, Gilead Sciences, San Francisco, CA (Moderator)
|
John Patrick Oroho, Esq.
Executive Vice President, Porzio Pharmaceutical Services, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ |
Don Soong
Senior Director, Compliance Solutions Development, Cegedim Dendrite, Bedminster, NJ
|
|
|
|
|
ADVISORS AND LEGAL COUNSEL
|
Eric M. Baim, Esq.
Associate, Hogan & Hartson, Washington, DC |
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, US Department of Justice, Washington, DC |
Jennifer Colapietro
Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers, Florham Park, NJ
|
Daniel F. Donovan, III, Esq.
Partner, Government Advocacy & Public Policy Practice Group , King & Spalding, Former Senior Investigative Counsel to Senator Charles E. Grassley (R-IA), Committee on Finance, US Senate, Washington, DC |
Michael N. Druckman, Esq.
Partner, Hogan & Hartson, Washington, DC |
Sarah K. Giesting, Esq.
Associate, Epstein Becker & Green, New York, NY
|
Jeffrey L. Handwerker, Esq.
Partner, Arnold & Porter, Washington, DC |
Marci Juneau
Manager, Life Sciences Advisory Services, Huron Consulting Group, Atlanta, GA |
William A. Sarraille, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC
|
Thomas Sullivan
President and Founder, Rockpointe Corporation, Columbia, MD |
Manny Tzavlakis
Director, Life Sciences Advisory Services, Huron Consulting Group, New York, NY |
Jon Wilkenfeld, MBA
President, Potomac River Partners, Vienna, VA |
|
|
|
|
THE TIME IS NOW FOR NEW, EFFICIENT AND COST EFFECTIVE ALTERNATIVES TO TRADITIONAL LEARNING APPROACHES
|
|
A variety of forces - the nation's economic crisis, costly and difficult air travel, the mandate for cost efficiency in healthcare, the proliferation of greater Internet bandwidth, the emergence of the popularity of online video via You Tube, and the explosion of online training in the health sector - has come together to create both a dramatic need and an extraordinary opportunity for innovative approaches to sharing new ideas and best practices. This Summit offers not only traditional conference attendance, but also to opportunity to attend the event live and archived online.
How can we be expected to reform the nation's health system if we can not reform the way we do our own business?
|
|
|
|
PARTICIPATION OPTIONS
|
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; facility interaction
LIVE AND ARCHIVED INTERNET ATTENDANCE
Watch the conference in live streaming video over the Internet and at your convenience
at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office |
|
INTERNET INTERFACE SAMPLE
|
Click here for a sample stream
|
|
|
|
|
THE GROUP REGISTRATION/ONLINE TRAINING ALTERNATIVE
|
|
By arranging to license online group access to the Summit Disclosure Summit Training Program, pharmaceutical, device and biotech companies subject to disclosure and aggregate spend requirements can implement company-wide online training programs. The company training coordinator can assign and track online participation. Successful completion of the training can be evidenced by passing the post conference training examination.
|
|
HERE IS AN EXAMPLE OF A PHARMA COMPANY DISCLOSURE TRAINING PROGRAM
|
|
|
|
|
|
